Baird Financial Statements From 2010 to 2026

BDMD Stock   1.32  0.02  1.49%   
Baird Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Baird Medical's valuation are provided below:
Gross Profit
27.7 M
Profit Margin
(0.1)
Market Capitalization
47.4 M
Enterprise Value Revenue
2.127
Revenue
31.9 M
There are over one hundred nineteen available fundamental signals for Baird Medical Investment, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Baird Medical's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of January 10, 2026, Market Cap is expected to decline to about 90.7 M. In addition to that, Enterprise Value is expected to decline to about 99.2 M

Baird Medical Total Revenue

29.63 Million

Check Baird Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Baird Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 696.4 K or Selling General Administrative of 5.7 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0613 or PTB Ratio of 3.97. Baird financial statements analysis is a perfect complement when working with Baird Medical Valuation or Volatility modules.
  
Build AI portfolio with Baird Stock
Check out the analysis of Baird Medical Correlation against competitors.

Baird Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets94.1 M89.7 M30.7 M
Slightly volatile
Short and Long Term Debt Total9.9 M18.8 M21.4 M
Slightly volatile
Other Current LiabilitiesM14.3 M6.7 M
Slightly volatile
Total Current Liabilities22.4 M39.8 M28.6 M
Slightly volatile
Property Plant And Equipment Net4.6 M8.8 M3.1 M
Slightly volatile
Accounts Payable1.5 M1.4 M375 K
Slightly volatile
Cash1.9 M3.4 MM
Slightly volatile
Non Current Assets Total9.7 M19 M6.4 M
Slightly volatile
Non Currrent Assets Other4.9 M9.4 M3.1 M
Slightly volatile
Cash And Short Term Investments2.1 M3.4 M1.1 M
Slightly volatile
Net Receivables56.2 M53.6 M16.4 M
Slightly volatile
Good Will49.3 K52 K59.8 K
Slightly volatile
Common Stock Shares Outstanding30.9 M29.5 M11 M
Slightly volatile
Short Term Investments205.8 K340.1 K117.5 K
Slightly volatile
Liabilities And Stockholders Equity94.1 M89.7 M30.6 M
Slightly volatile
Non Current Liabilities Total4.3 M4.1 M1.4 M
Slightly volatile
Inventory1.5 M1.5 MM
Slightly volatile
Other Current Assets12.8 M12.2 MM
Slightly volatile
Total Liabilities24 M43.9 M29.9 M
Slightly volatile
Total Current Assets74.2 M70.6 M23.7 M
Slightly volatile
Short Term DebtM15.6 M20.3 M
Slightly volatile
Intangible Assets14.1 K14.9 K101.6 K
Slightly volatile
Current Deferred Revenue590.9 K910.9 K246.3 K
Slightly volatile
Capital Lease Obligations438.1 K461.1 K975.8 K
Very volatile
Net Invested Capital42.3 M69.2 M26.9 M
Slightly volatile
Property Plant And Equipment Gross9.2 M14 M6.8 M
Slightly volatile
Short and Long Term Debt20.6 M19.6 M5.7 M
Slightly volatile
Capital Stock2.3 KK811
Slightly volatile
Net Working Capital21.3 M30.8 M15.2 M
Slightly volatile
Common StockK2.3 K9.1 K
Slightly volatile
Long Term Debt2.8 MM1.9 M
Slightly volatile

Baird Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.2 M1.7 M728.8 K
Slightly volatile
Interest Expense696.4 K663.3 K219.4 K
Slightly volatile
Selling General Administrative5.7 M6.8 M3.1 M
Slightly volatile
Selling And Marketing Expenses3.6 M4.7 M3.2 M
Slightly volatile
Total Revenue29.6 M42.6 M20.2 M
Slightly volatile
Gross Profit25.2 M37.6 M17.6 M
Slightly volatile
Other Operating Expenses16.7 M25 M11.3 M
Slightly volatile
Operating Income12.5 M17.6 M8.8 M
Slightly volatile
EBIT12.7 M16.9 M8.7 M
Slightly volatile
Research Development7.5 M7.1 M2.5 M
Slightly volatile
EBITDA13.9 M18.6 M9.5 M
Slightly volatile
Cost Of Revenue4.4 MM2.7 M
Slightly volatile
Total Operating Expenses12.2 M19.9 M8.6 M
Slightly volatile
Income Tax Expense1.5 M1.3 M1.5 M
Slightly volatile
Tax Provision1.5 M1.3 M2.2 M
Slightly volatile
Interest Income3363542.3 K
Pretty Stable
Net Income From Continuing Ops12.7 M14.5 M10.9 M
Slightly volatile
Reconciled Depreciation1.6 M1.7 M1.4 M
Slightly volatile

Baird Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.4 M1.7 M959.4 K
Slightly volatile
Capital Expenditures2.7 M3.3 M1.7 M
Slightly volatile
End Period Cash Flow1.9 M3.4 MM
Slightly volatile
Begin Period Cash Flow1.7 M1.7 M773.3 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.986.034.8812
Slightly volatile
Dividend Yield0.06130.06890.0752
Slightly volatile
Days Sales Outstanding434413213
Slightly volatile
Average Payables851.8 K811.3 K331.4 K
Slightly volatile
Capex To Depreciation1.461.71.6492
Pretty Stable
EV To Sales4.626.596.3983
Slightly volatile
ROIC0.250.260.7765
Slightly volatile
Inventory Turnover2.533.042.4115
Slightly volatile
Days Of Inventory On Hand153124171
Slightly volatile
Payables Turnover3.824.0213.8636
Pretty Stable
Sales General And Administrative To Revenue0.140.15940.1261
Slightly volatile
Average Inventory1.3 MM1.2 M
Slightly volatile
Research And Ddevelopement To Revenue0.07820.150.098
Pretty Stable
Capex To Revenue0.06630.06930.0799
Very volatile
Cash Per Share0.180.10.1123
Slightly volatile
Interest Coverage57.8830.5456.9123
Slightly volatile
Payout Ratio0.370.420.4565
Slightly volatile
Days Payables Outstanding98.5793.8839.6121
Slightly volatile
ROE0.340.360.4885
Pretty Stable
Intangibles To Total Assets0.0010.00110.0115
Slightly volatile
Current Ratio1.331.60.8945
Slightly volatile
Receivables Turnover0.870.912.1296
Slightly volatile
Graham Number6.363.715.7092
Slightly volatile
Capex Per Share0.09550.10.1915
Pretty Stable
Average Receivables19.2 M35.1 M15.5 M
Slightly volatile
Revenue Per Share2.571.32.2599
Slightly volatile
Interest Debt Per Share1.550.972.7843
Slightly volatile
Debt To Assets0.290.311.5397
Slightly volatile
Enterprise Value Over EBITDA9.7615.0813.4884
Slightly volatile
Operating Cycle318510367
Slightly volatile
Days Of Payables Outstanding98.5793.8839.6121
Slightly volatile
Dividend Payout Ratio0.370.420.4565
Slightly volatile
Operating Profit Margin0.480.41350.4534
Pretty Stable
Long Term Debt To Capitalization0.06390.07190.0785
Slightly volatile
Total Debt To Capitalization0.380.42.5506
Slightly volatile
Ebit Per Revenue0.480.41350.4534
Pretty Stable
Quick Ratio1.251.560.841
Slightly volatile
Net Income Per E B T1.011.021.0932
Slightly volatile
Cash Ratio0.0960.07720.0551
Slightly volatile
Cash Conversion Cycle288416331
Slightly volatile
Days Of Inventory Outstanding153124171
Slightly volatile
Days Of Sales Outstanding434413213
Slightly volatile
Fixed Asset Turnover8.125.597.3022
Very volatile
Enterprise Value Multiple9.7615.0813.4884
Slightly volatile
Debt Ratio0.290.311.5397
Slightly volatile
Price Sales Ratio3.986.034.8812
Slightly volatile
Asset Turnover0.920.550.9314
Slightly volatile
Gross Profit Margin0.951.010.8906
Pretty Stable
Return On Equity0.340.360.4885
Pretty Stable

Baird Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap90.7 M174.8 M81.1 M
Slightly volatile
Enterprise Value99.2 M190.9 M88.5 M
Slightly volatile

Baird Fundamental Market Drivers

About Baird Medical Financial Statements

Baird Medical stakeholders use historical fundamental indicators, such as Baird Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Baird Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Baird Medical's assets and liabilities are reflected in the revenues and expenses on Baird Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Baird Medical Investment. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue910.9 K590.9 K
Total Revenue42.6 M29.6 M
Cost Of RevenueM4.4 M
Sales General And Administrative To Revenue 0.16  0.14 
Research And Ddevelopement To Revenue 0.15  0.08 
Capex To Revenue 0.07  0.07 
Revenue Per Share 1.30  2.57 
Ebit Per Revenue 0.41  0.48 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Baird Medical Investment is a strong investment it is important to analyze Baird Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Baird Medical's future performance. For an informed investment choice regarding Baird Stock, refer to the following important reports:
Check out the analysis of Baird Medical Correlation against competitors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baird Medical. If investors know Baird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baird Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0)
Earnings Share
(0.11)
Revenue Per Share
1.226
Quarterly Revenue Growth
(0.39)
Return On Assets
(0)
The market value of Baird Medical Investment is measured differently than its book value, which is the value of Baird that is recorded on the company's balance sheet. Investors also form their own opinion of Baird Medical's value that differs from its market value or its book value, called intrinsic value, which is Baird Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baird Medical's market value can be influenced by many factors that don't directly affect Baird Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baird Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baird Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.